Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Infusions for Pediatric Asthma Exacerbations
NCT01522040Phase 3Withdrawn
- Sponsor
- University of Louisville
- Start
- Jan 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium sulfate in asthma (2 arms), sponsored by University of Louisville. Primary endpoint: Time from patient presentation until PICU discharge. Planned start Jan 2012; status: withdrawn.
02
Drugs
magnesium sulfate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01522040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01522040.